Advocacy intelligence hub — real-time data for patient organizations
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. — PHASE2
Milton S. Hershey Medical Center
National Cancer Institute (NCI) — PHASE2
Grupo Espanol de Investigacion en Sarcomas — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Halaven
(eribulin mesylate)Orphan drugstandardEisai Inc.
12.1 Mechanism of Action Eribulin inhibits the growth phase of microtubules without affecting the shortening phase and sequesters tubulin into nonprod...
Yondelis
(trabectedin)Orphan drugstandardJanssen Research & Development, LLC
Alkylating Drug [EPC]
12.1 Mechanism of Action Trabectedin is an alkylating drug that binds guanine residues in the minor groove of DNA, forming adducts and resulting in a ...